A detailed history of Tower View Investment Management & Research LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tower View Investment Management & Research LLC holds 10,050 shares of LLY stock, worth $8 Million. This represents 5.15% of its overall portfolio holdings.

Number of Shares
10,050
Previous 10,078 0.28%
Holding current value
$8 Million
Previous $9.12 Million 2.42%
% of portfolio
5.15%
Previous 5.52%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $21,619 - $26,880
-28 Reduced 0.28%
10,050 $8.9 Million
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $15,947 - $19,998
-22 Reduced 0.22%
10,078 $9.12 Million
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $1 Million - $1.34 Million
-1,693 Reduced 14.36%
10,100 $7.86 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $202,723 - $238,984
-386 Reduced 3.17%
11,793 $6.87 Million
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $827,234 - $1.14 Million
-1,903 Reduced 13.51%
12,179 $6.54 Million
Q2 2023

Jul 31, 2023

SELL
$350.74 - $468.98 $458,066 - $612,487
-1,306 Reduced 8.49%
14,082 $6.6 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $25,782 - $30,280
-83 Reduced 0.54%
15,388 $5.28 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $249,844 - $291,118
-777 Reduced 4.78%
15,471 $5.66 Million
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $21,050 - $23,988
71 Added 0.44%
16,248 $5.25 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $105,638 - $124,035
-379 Reduced 2.29%
16,177 $5.25 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $55,856 - $69,415
238 Added 1.46%
16,556 $4.74 Million
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $40,473 - $50,227
180 Added 1.12%
16,318 $4.51 Million
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $548,238 - $674,684
-2,474 Reduced 13.29%
16,138 $3.73 Million
Q2 2021

Jul 28, 2021

SELL
$180.55 - $233.54 $295,740 - $382,538
-1,638 Reduced 8.09%
18,612 $4.27 Million
Q1 2021

Apr 23, 2021

SELL
$164.32 - $212.72 $611,599 - $791,743
-3,722 Reduced 15.53%
20,250 $3.78 Million
Q4 2020

Jan 26, 2021

SELL
$130.46 - $172.63 $258,049 - $341,462
-1,978 Reduced 7.62%
23,972 $4.05 Million
Q3 2020

Oct 19, 2020

BUY
$146.22 - $169.13 $90,948 - $105,198
622 Added 2.46%
25,950 $3.84 Million
Q2 2020

Aug 03, 2020

BUY
$136.42 - $164.18 $26,601 - $32,015
195 Added 0.78%
25,328 $4.16 Million
Q4 2019

Jan 13, 2020

BUY
$106.92 - $132.43 $34,962 - $43,304
327 Added 1.32%
25,133 $3.3 Million
Q3 2019

Oct 09, 2019

BUY
$106.79 - $116.16 $27,765 - $30,201
260 Added 1.06%
24,806 $2.77 Million
Q2 2019

Jul 17, 2019

BUY
$110.79 - $129.32 $53,843 - $62,849
486 Added 2.02%
24,546 $2.72 Million
Q1 2019

Apr 16, 2019

BUY
$111.31 - $131.02 $2.66 Million - $3.13 Million
23,903 Added 15224.84%
24,060 $3.12 Million
Q3 2018

Oct 12, 2018

BUY
$85.86 - $107.31 $85 - $107
1 Added 0.64%
157 $17,000
Q2 2018

Jul 23, 2018

BUY
$75.7 - $86.88 $75 - $86
1 Added 0.65%
156 $13,000
Q1 2018

Apr 10, 2018

BUY
$74.21 - $87.6 $74 - $87
1 Added 0.65%
155 $12,000
Q4 2017

Jan 24, 2018

BUY
$81.94 - $87.89 $12,618 - $13,535
154
154 $13,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tower View Investment Management & Research LLC Portfolio

Follow Tower View Investment Management & Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.